NI
Nextech Invest Portfolio holdings
AUM
$528M
This Quarter Return
+32.13%
1 Year Return
-0.88%
3 Year Return
+164%
5 Year Return
–
10 Year Return
–
AUM
$528M
AUM Growth
+$528M
(+23%)
Cap. Flow
+$34.8M
Cap. Flow
% of AUM
6.59%
Top 10 Holdings %
Top 10 Hldgs %
93.84%
Holding
16
New
1
Increased
2
Reduced
1
Closed
–
Top Buys
| 1 |
Oric Pharmaceuticals
ORIC
|
$19.1M |
| 2 |
Kymera Therapeutics
KYMR
|
$14.9M |
| 3 |
ALMS
Alumis Inc. Common Stock
ALMS
|
$4.32M |
Top Sells
| 1 |
ARS Pharmaceuticals
SPRY
|
$3.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$7.1B
| $280M | 52.92% | 7,601,087 | – | – |
|
|
2
Oric Pharmaceuticals
ORIC
$994M
| $72.7M | 13.76% | 7,162,637 +1,876,923 | +36% | +$19.1M |
|
3
Tyra Biosciences
TYRA
$675M
| $38.8M | 7.35% | 4,055,861 | – | – |
|
4
Tango Therapeutics
TNGX
$747M
| $28.3M | 5.36% | 5,533,980 | – | – |
|
|
5
Kymera Therapeutics
KYMR
$2.95B
| $14.9M | 2.82% | +340,909 | New | +$14.9M |
|
6
Zymeworks
ZYME
$1.12B
| $14M | 2.65% | 1,113,946 | – | – |
|
7
Relay Therapeutics
RLAY
$619M
| $13.3M | 2.52% | 3,846,409 | – | – |
|
|
8
ARS Pharmaceuticals
SPRY
$1.15B
| $12.9M | 2.45% | 741,729 -195,000 | -21% | -$3.4M |
|
|
CRGX
9
DELISTED
CARGO Therapeutics
CRGX
| $10.9M | 2.06% | 2,642,502 | – | – |
|
10
Arvinas
ARVN
$568M
| $10.4M | 1.96% | 1,408,394 | – | – |
|
|
ALMS
11
Alumis Inc. Common Stock
ALMS
$479M
| $8.75M | 1.66% | 2,915,998 +1,439,000 | +97% | +$4.32M |
|
12
Cullinan Oncology
CGEM
$445M
| $8.59M | 1.63% | 1,141,145 | – | – |
|
|
SLN
13
Silence Therapeutics
SLN
$227M
| $5.52M | 1.05% | 952,400 | – | – |
|
14
Context Therapeutics
CNTX
$75.4M
| $4.86M | 0.92% | 7,419,355 | – | – |
|
15
Mersana Therapeutics
MRSN
$36.5M
| $3.57M | 0.68% | 12,067,246 | – | – |
|
|
BOLD
16
Boundless Bio
BOLD
$25.1M
| $1.24M | 0.23% | 1,228,069 | – | – |
|